Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAs

Similarity of expression changes in neurons from Alzheimer's disease brain and neuronal cells treated with OAβ, and the effect of a CoQ10 analogue on the latter, suggests a pretreatment option to prevent OAβ toxicity, long before the damage is apparent.